Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewsBusiness

Infosys' CEO Salil Parekh's salary rises 27% YoY to $6.15 million in FY20

For FY19 period, his remuneration was $4.8 million.

May 31, 2020 / 07:11 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Infosys CEO Salil Parekh raked in $6.15 million in FY20, up 27 percent, compared to last year, according to the US Securities and Exchanges Commission filing.

This includes $801,264 in salary, $1.54 million in bonus and incentives, $53,425 in long term benefits and $3.7 million in restricted stock units.

For FY19 period, his remuneration was $4.8 million.

UB Pravin Rao, COO, Infosys, remuneration jumped from $1.78 million in FY19 to $2.3 million in 2019-20.

His remuneration includes salary, bonuses and incentives and RSUs valued at $1.1 million for the year ending March 31, 2020.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Employee and subcontractor cost increased close to 10 percent each. Sub-contractor cost increased to $945 million in FY20, compared to $860 million for the same period last year. Employee costs increased from $5780 million to $6406 million.

The rise was mainly on an account of increase in compensation and usage of technical sub-contractors to meet the talent crunch, the statement added.

While the Infosys’ remuneration increased, remuneration of its counterparts in TCS declined at the back of COVID-19.

In the annual report, the company said, “The managerial remuneration for the year decreased by 15 percent. The executive remuneration for FY2020 is lower than FY2019 in view of the economic conditions impacted by the COVID-19 pandemic. The Directors have decided to moderate the executive remuneration for this year to express solidarity and conserve resources.”

Rajesh Gopinathan’s salary fell 16 percent from Rs 16.02 crore to Rs 13.3 crore. Remuneration of N Ganapathy Subramaniam, COO, declined by 12.9 percent primarily due to lower commissions. His salary stood at Rs 10. 11 crore, according to reports.
Moneycontrol News
first published: May 31, 2020 07:08 pm

stay updated

Get Daily News on your Browser
Sections